Cancer.Net Podcasts
Cancer.Net Podcasts
Cancer.Net is pleased to offer its patient information on cancer research, treatment, coping, and many other topics in an audio podcast format. This gives people with cancer and their families and friends an additional option of how they'd like to receive oncologist-approved information from Cancer.Net.
The Cancer.Net Podcasts series has been awarded a Merit Award in the Digital Health Awards competition, which recognizes high-quality digital health resources for consumers and health professionals. The awards are organized by the Health Information Resource Center. Learn more about Cancer.Net awards and recognition.
Explaining Podcasts
A Cancer.Net Podcast is a pre-recorded audio file in which a specific cancer-related topic is addressed in order to assist people with cancer. A podcast can be listened to online or downloaded to your computer free of charge. After downloading, a Cancer.Net Podcast may also be transferred to an MP3 audio player, such as an iPod. To download or listen to a Cancer.Net Podcast on your computer, you will need software capable of playing MP3 files, such as Windows Media Player or QuickTime. Cancer.Net Podcasts are edited for content and length. Full written transcripts are available.
You may also want to subscribe to Cancer.Net Podcasts, so that new offerings are automatically downloaded to your personal computer as soon as they are available. To subscribe, copy and paste the link below into software that allows podcast subscriptions, such as iTunes.
Podcast transcripts were funded (in part) by the Conquer Cancer Mission Endowment Fund.
Today we're going to be talking about the psychosocial challenges unique to survivors of gynecologic cancers and how survivorship care plans can be helpful to survivors of these cancers. Our guests today are Dr. Fay Hlubocky and Dr. Merry Jennifer Markham. Dr. Hlubocky is a licensed clinical health psychologist with an expertise in psychosocial oncology and a health care ethicist at the University of Chicago in Chicago, Illinois. She is also the Cancer.Net Associate Editor for Psychosocial Oncology. Dr. Markham is Chief of the Division of Hematology and Oncology and a clinical professor in the Department of Medicine at the University of Florida in Gainesville, Florida. She is also the Cancer.Net Associate Editor for Gynecologic Cancers.
In this podcast, Dr. Kedar Kirtane discusses new research from the 2022 Multidisciplinary Head and Neck Cancers Symposium, held February 24-26 in Phoenix, Arizona, including research on disparities in head and neck cancer, treatment for HPV-positive oropharyngeal cancer, and strategies for reducing side effects from treatment while still keeping high effectiveness.
Today, we're going to be talking about the ASCO provisional clinical opinion, “Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer.” Our guests today are the co-chairs of the team that wrote these recommendations. Dr. Funda Meric-Bernstam from the University of Texas MD Anderson Cancer Center in Houston, Texas and Dr. Mark Robson from Memorial Sloan Kettering Cancer Center in New York City.
In this podcast, Dr. Christopher Flowers covers highlights from the 2021 American Society of Hematology Annual Meeting, held December 11 to 14 in Atlanta, Georgia. He discusses new treatments for diffuse large B-cell lymphoma, advances in immunotherapy, and a session on improving inclusivity in clinical trials.
In this podcast, Cancer.Net Associate Editor Dr. Norah Lynn Henry will discuss new research presented at the 2021 San Antonio Breast Cancer Symposium, held December 7-10, 2022.
In this podcast, experts will discuss targeted therapy for lung cancer, including 2 new treatments that target a specific type of mutation or change in the EGFR gene in some cancer cells, called an EGFR exon 20 insertion. They will explain how targeted therapy works to treat cancer, why this specific mutation is different from other, more common EGFR mutations, and what these 2 new treatments mean for people with this type of cancer.
In this podcast, Dr. Tian Zhang and Dr. Afreen Shariff discuss common and sometimes serious side effects caused by a type of immunotherapy called “immune checkpoint inhibitors.” They also explain why it is important for people with cancer to track the side effects they experience and discuss them with their health care team.
In today’s episode, Cancer.Net Associate Editors discuss new research in brain tumors and gastrointestinal cancers presented at the 2021 ASCO Annual Meeting, held virtually June 4-8. First, Dr. Glenn Lesser will discuss new research in 2 types of brain tumors, craniopharyngioma and glioblastoma. Next, Dr. Jeffrey Meyerhardt will discuss new research in esophageal and colorectal cancer.
In this podcast, we're going to be discussing how parents can talk with their children about a metastatic cancer diagnosis and their prognosis. The information discussed in this podcast is based on a study published in JCO Oncology Practice titled, “Talking with Children About Prognosis: The Decisions and Experiences of Mothers with Metastatic Cancer.” Our guests today are Dr. Eliza Park and Dr. Paula Rauch. Dr. Park served as the lead author on the study, and Dr. Rauch served as a co-author on the study.
In the Research Round Up series, members of the Cancer.Net Editorial Board discuss the most exciting and practice-changing research in their field and explain what it means for people with cancer. In today’s episode, 3 Cancer.Net Associate Editors discuss new research in cervical cancer, melanoma, and cancer in adults 65 and over, presented at the 2021 ASCO Annual Meeting, held virtually June 4th through 8th.
This episode has been adapted from the recording of a live Cancer.Net webinar, held August 9th, and led by Dr. Merry Jennifer Markham, Dr. Ryan Sullivan, and Dr. William Dale.